Morgan Stanley’s Arcosa ACA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50.9M | Sell |
479,177
-64,371
| -12% | -$7.32M | ﹤0.01% | 2082 |
|
|
2025
Q4 | $57.8M | Buy |
543,548
+6,219
| +1% | +$628K | ﹤0.01% | 1943 |
|
|
2025
Q3 | $50.4M | Sell |
537,329
-47,086
| -8% | -$4.38M | ﹤0.01% | 2002 |
|
|
2025
Q2 | $50.7M | Buy |
584,415
+20,873
| +4% | +$1.75M | ﹤0.01% | 1919 |
|
|
2025
Q1 | $43.5M | Sell |
563,542
-45,731
| -8% | -$4.2M | ﹤0.01% | 1937 |
|
|
2024
Q4 | $58.9M | Buy |
609,273
+33,876
| +6% | +$3.41M | ﹤0.01% | 1689 |
|
|
2024
Q3 | $54.5M | Sell |
575,397
-102,476
| -15% | -$8.95M | ﹤0.01% | 1748 |
|
|
2024
Q2 | $56.5M | Buy |
677,873
+136,424
| +25% | +$11.4M | ﹤0.01% | 1639 |
|
|
2024
Q1 | $46.5M | Sell |
541,449
-786,367
| -59% | -$64M | ﹤0.01% | 1823 |
|
|
2023
Q4 | $110M | Buy |
1,327,816
+646,829
| +95% | +$47.5M | ﹤0.01% | 1632 |
|
|
2023
Q3 | $49M | Buy |
680,987
+91,092
| +15% | +$6.91M | 0.01% | 1601 |
|
|
2023
Q2 | $44.7M | Buy |
589,895
+45,889
| +8% | +$3.09M | ﹤0.01% | 1674 |
|
|
2023
Q1 | $34.3M | Sell |
544,006
-54,081
| -9% | -$3.17M | ﹤0.01% | 1893 |
|
|
2022
Q4 | $32.5M | Buy |
598,087
+93,427
| +19% | +$5.55M | ﹤0.01% | 1889 |
|
|
2022
Q3 | $28.9M | Buy |
504,660
+42,506
| +9% | +$2.36M | ﹤0.01% | 1809 |
|
|
2022
Q2 | $21.5M | Buy |
462,154
+161,917
| +54% | +$8.48M | ﹤0.01% | 2218 |
|
|
2022
Q1 | $17.2M | Sell |
300,237
-49,368
| -14% | -$2.54M | ﹤0.01% | 2278 |
|
|
2021
Q4 | $18.4M | Buy |
349,605
+92,495
| +36% | +$4.95M | ﹤0.01% | 2254 |
|
|
2021
Q3 | $12.9M | Buy |
257,110
+6,313
| +3% | +$327K | ﹤0.01% | 2595 |
|
|
2021
Q2 | $14.7M | Buy |
250,797
+39,475
| +19% | +$2.44M | ﹤0.01% | 2525 |
|
|
2021
Q1 | $13.8M | Sell |
211,322
-27,515
| -12% | -$1.69M | ﹤0.01% | 2316 |
|
|
2020
Q4 | $13.1M | Buy |
238,837
+43,538
| +22% | +$2.22M | ﹤0.01% | 2237 |
|
|
2020
Q3 | $8.61M | Sell |
195,299
-8,037
| -4% | -$353K | ﹤0.01% | 2159 |
|
|
2020
Q2 | $8.58M | Sell |
203,336
-3,121
| -2% | -$120K | ﹤0.01% | 2110 |
|
|
2020
Q1 | $8.2M | Sell |
206,457
-107,428
| -34% | -$4.54M | ﹤0.01% | 1951 |
|
|
2019
Q4 | $14M | Buy |
313,885
+104,014
| +50% | +$4M | ﹤0.01% | 2029 |
|
|
2019
Q3 | $7.18M | Sell |
209,871
-55,820
| -21% | -$1.93M | ﹤0.01% | 2474 |
|
|
2019
Q2 | $10M | Buy |
265,691
+215,191
| +426% | +$7.36M | ﹤0.01% | 2163 |
|
|
2019
Q1 | $1.54M | Sell |
50,500
-290,770
| -85% | -$8.88M | ﹤0.01% | 3798 |
|
|
2018
Q4 | $9.45M | Buy |
+341,270
| New | +$9.38M | ﹤0.01% | 2196 |
|
Other funds holding ACA
VPM
VCM
RA
Morgan Stanley's ACA Position: Q1 2026 in Review
Morgan Stanley reduced its Arcosa (ACA) stake by 12% in Q1 2026, selling an estimated $7.32M and leaving 479,177 shares worth $50.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2082.
Morgan Stanley first reported a position in ACA in Q4 2018 and has held it in 30 quarters since. The position peaked at $110M in Q4 2023. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.
- Morgan Stanley held 479,177 shares of Arcosa worth $50.9M as of Q1 2026.
- Morgan Stanley sold 64,371 Arcosa shares in Q1 2026, an estimated $7.32M.
- Arcosa made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2082 holding.
- Morgan Stanley first reported a position in Arcosa in Q4 2018 and has held it in 30 quarters since.
- Morgan Stanley's Arcosa position peaked at $110M in Q4 2023.
- 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.